Back to Search Start Over

MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD)

Source :
Plus Company Updates. December 7, 2024
Publication Year :
2024

Abstract

NEW YORK: Mind Medicine Inc. has issued the following news release: Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the 'Company' or 'MindMed'), a clinical-stage biopharmaceutical company developing novel product candidates to [...]

Subjects

Subjects :
Innovations
Anxiety
Passports

Details

Language :
English
Database :
Gale General OneFile
Journal :
Plus Company Updates
Publication Type :
News
Accession number :
edsgcl.819360612